90 likes | 103 Views
Learn about the Congressionally Directed Medical Research Programs (CDMRP), its history, and the potential threats it faces from the National Defense Authorization Act (NDAA). Find out how you can help advocate for the protection of medical research funding at the Department of Defense (DoD) and join the #ResearchNotRedTape Twitter campaign. Contact your representative and urge them to cosign the Costello-King-Bishop-Loebsack letter to safeguard medical research at DoD.
E N D
Congressionally Directed Medical Research Programs Brief Overview By Mark Vieth, Coordinator Defense Health Research Consortium
CDMRP History and Brief Facts • Established by Congress in Fiscal Year 1992 • Funded Annually by Defense Appropriations Act • Total Appropriations FY92-17: $11.9 Billion • Total grants/contracts awarded FY92-15: 14,829 • Includes dozens of programs directed by Congress: • Disease Specific: Breast Cancer, Prostate Cancer, NF, Tuberous Sclerosis • “Catch All”: Peer Reviewed Cancer Research Program (14 cancers) Peer Review Medical Research Program (dozens of conditions) • FY97: Prostate Cancer Research Program Funded at $90 million
Defense Health Research Consortium • Coalition of 35 patient advocacy, medical provider and veterans organizations. • Includes ZERO, Prostate Cancer Foundation, American Urological Association, US TOO. • Advocates for funding of medical research at DoD (CDMRP). • $1+ billion portfolio, including $90 million for PRCRP in FY17. • Advocate on annual Appropriations and Authorizations. • Website: www.defensehealthresearch.org
National Defense Authorization Act (NDAA) • Senate Bill includes four sections harmful to CDMRP - Narrowly defines what research is eligible - Adds red tape contracting and auditing requirements for grants - DOD: “impact force readiness and medical providers’ readiness.” - DOD: “eliminate military family and military retiree-relevant medical research and development, inhibit military medical training programs, and impact future health care cost avoidance.”
National Defense Authorization Act (NDAA) • Bipartisan amendment filed by Senators Durbin (D-IL) and Blunt (R-MO) to nullify egregious provisions. • Cosponsored by 53 (majority) Senators! • Never Received a Vote • Conference Strategy: - Durbin-Blunt letter signed by 54 Senators - Bipartisan House letter: 60 House members Deadline: October 18
How You Can Help! • #ResearchNotRedTapeTwitter campaign https://twitter.com/hashtag/researchnotredtape?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Ehashtag • Contact Your Representative! www.house.gov Senate letter closed • Urge them to cosign the Costello-King-Bishop-Loebsack letter to protect medical research at DoD!